Cardiovascular Systems Inc. (CSII) Sets New 1-Year High at $24.85
Cardiovascular Systems Inc. (NASDAQ:CSII)’s share price reached a new 52-week high during trading on Wednesday . The stock traded as high as $24.85 and last traded at $24.58, with a volume of 138,774 shares trading hands. The stock had previously closed at $24.34.
Several research firms have commented on CSII. Zacks Investment Research upgraded shares of Cardiovascular Systems from a “hold” rating to a “buy” rating and set a $24.00 price objective on the stock in a report on Monday, August 8th. Bank of America Corp. upgraded shares of Cardiovascular Systems from an “underperform” rating to a “neutral” rating in a report on Thursday, August 4th. Needham & Company LLC upped their price target on shares of Cardiovascular Systems from $23.00 to $27.00 and gave the company a “buy” rating in a research note on Thursday, August 4th. Finally, Leerink Swann upgraded shares of Cardiovascular Systems from a “market perform” rating to an “outperform” rating and set a $30.00 price target on the stock in a research note on Monday. Two investment analysts have rated the stock with a hold rating and seven have assigned a buy rating to the company’s stock. The company has an average rating of “Buy” and a consensus target price of $23.71.
The stock has a 50 day moving average price of $20.66 and a 200 day moving average price of $15.30. The stock’s market cap is $778.69 million.
Cardiovascular Systems (NASDAQ:CSII) last issued its quarterly earnings data on Wednesday, August 3rd. The medical device company reported ($0.15) earnings per share for the quarter, beating the consensus estimate of ($0.20) by $0.05. The company had revenue of $48.50 million for the quarter, compared to the consensus estimate of $46.01 million. During the same quarter last year, the business posted ($0.27) earnings per share. Cardiovascular Systems’s revenue was up .0% on a year-over-year basis. Analysts predict that Cardiovascular Systems Inc. will post ($0.62) EPS for the current fiscal year.
In other Cardiovascular Systems news, CFO Laurence L. Betterley sold 3,568 shares of the firm’s stock in a transaction on Monday, August 22nd. The stock was sold at an average price of $23.96, for a total transaction of $85,489.28. Following the transaction, the chief financial officer now directly owns 253,031 shares in the company, valued at approximately $6,062,622.76. The sale was disclosed in a document filed with the SEC, which is available through this hyperlink. Also, COO Kevin J. Kenny sold 3,166 shares of the firm’s stock in a transaction on Monday, August 22nd. The shares were sold at an average price of $23.95, for a total value of $75,825.70. Following the transaction, the chief operating officer now owns 168,231 shares in the company, valued at $4,029,132.45. The disclosure for this sale can be found here.
A hedge fund recently raised its stake in Cardiovascular Systems stock. Schwab Charles Investment Management Inc. increased its stake in shares of Cardiovascular Systems Inc. (NASDAQ:CSII) by 3.1% during the fourth quarter, according to its most recent filing with the SEC. The fund owned 98,841 shares of the medical device company’s stock after buying an additional 2,932 shares during the period. Schwab Charles Investment Management Inc. owned 0.30% of Cardiovascular Systems worth $1,495,000 as of its most recent filing with the SEC.
Cardiovascular Systems, Inc is a medical technology company. The Company is engaged in treating patients suffering from peripheral and coronary arterial diseases. It has developed an orbital atherectomy technology for peripheral and coronary commercial applications. Its peripheral arterial disease systems are catheter-based platforms that treat plaque types in leg arteries both above and below the knee.
Get Analysts' Upgrades and Downgrades Daily - Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.